Updated patent review for hematopoietic progenitor kinase (HPK1) inhibitors and degraders (2021-present).

已完结 10 由 Lee930217 发布于 2026/9/9 16:52:48

DOI:10.1080/13543776.2025.2462834
作者：Ying-Hui Yuan,?Jia-Ying Mao,?Ji-Fan Yue,?Meng-Lan He,?Zi Hui,?Hang Yin,?Jianshe Wang,?Xiang-Yang Ye
文献类型：期刊论文
补充材料：只需要正文

Taylor & Francis

Abstract：Introduction: Hematopoietic progenitor cell kinase (HPK1) is a serine/threonine kinase of MAP4K family. It negatively regulates T cell receptor and B cell signal transduction. The loss of HP

应助信息

3小时前

Book学术机器人

1f4fc4381ea611f0b06334735aa3bc31.pdf 已采纳

3小时前

Book学术机器人

2026/9/9 16:52:48 Book学术AI机器人已找到文献并上传

2026/9/9 16:52:48 Book学术AI机器人收到请求，开始寻找文献

2026/9/9 16:52:48 已向机器人发送请求

3小时前

Lee930217 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierIdentification of phenolics in the fruit of emblica (Phyllanthus emblica L.) and their antioxidant activities